Effect of pharmaceutical formulation on gastrointestinal bleeding from aspirin tablets.
D000284:Administration, Oral; D000328:Adult; D000863:Antacids / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D002021:Buffers; D002859:Chromium Isotopes; D005260:Female; D005745:Gastric Acidity Determination; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008297:Male; D008551:Melena / Q000139:chemically induced; D010592:Pharmaceutic Aids; D012995:Solubility; D013607:Tablets; D013997:Time Factors
D000863:Antacids; D002021:Buffers; D002859:Chromium Isotopes; D010592:Pharmaceutic Aids; D013607:Tablets; D001241:Aspirin